Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2013Frontiers in ImmunologyOpen Access

Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMarkus SteinPRPaolo RuggieroRRRino Rappuoli

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stein et al. (2013) studied this question.

synapsesocial.com/papers/6a82db4672d82bb027239e20https://doi.org/10.3389/fimmu.2013.00328
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1c‐Src/Lyn kinases activate <i>Helicobacter pylori</i> CagA through tyrosine phosphorylation of the EPIYA motifs2002 · 438 citations
  2. 2E‐cadherin dysfunction in gastric cancer ‐ Cellular consequences, clinical applications and open questions2012 · 86 citations